Additionally, individuals with higher body mass index and heart disease can significantly reduce their risk of cardiovascular disease through effective weight loss strategies
Two people with Aetna cards can have completely different coverage and a plan that covers Wegovy may not cover Zepbound, or vice versa
It belongs to the drug class known as GLP-1 receptor agonists (Incretin Mimetics)
NAD&MNM: NAD & MNM boost mitochondrial energy metabolism, enhance cellular repair, and accelerate fat burning
Phen-Fen (phentermine + fenfluramine) was the GLP-1 of its day effective for weight loss, but discontinued in 1997 for causing heart-valve damage and pulmonary hypertension
The patient's member portal usually has this information under "find a drug" or "drug list." If the portal is unclear, calling the pharmacy benefit manager (PBM) not the medical plan and asking specifically about Wegovy, Zepbound, Ozempic, and Mounjaro by name will produce the cleanest answer